JP2008532931A5 - - Google Patents

Download PDF

Info

Publication number
JP2008532931A5
JP2008532931A5 JP2007554330A JP2007554330A JP2008532931A5 JP 2008532931 A5 JP2008532931 A5 JP 2008532931A5 JP 2007554330 A JP2007554330 A JP 2007554330A JP 2007554330 A JP2007554330 A JP 2007554330A JP 2008532931 A5 JP2008532931 A5 JP 2008532931A5
Authority
JP
Japan
Prior art keywords
amino acid
acid number
seq
acid sequence
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007554330A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008532931A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/004311 external-priority patent/WO2006086396A2/en
Publication of JP2008532931A publication Critical patent/JP2008532931A/ja
Publication of JP2008532931A5 publication Critical patent/JP2008532931A5/ja
Withdrawn legal-status Critical Current

Links

JP2007554330A 2005-02-08 2006-02-08 抗il−20、抗il−22および抗il−22ra抗体ならびに結合パートナー、ならびに炎症における使用法 Withdrawn JP2008532931A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65083005P 2005-02-08 2005-02-08
PCT/US2006/004311 WO2006086396A2 (en) 2005-02-08 2006-02-08 Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation

Publications (2)

Publication Number Publication Date
JP2008532931A JP2008532931A (ja) 2008-08-21
JP2008532931A5 true JP2008532931A5 (enExample) 2009-03-26

Family

ID=36752302

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007554330A Withdrawn JP2008532931A (ja) 2005-02-08 2006-02-08 抗il−20、抗il−22および抗il−22ra抗体ならびに結合パートナー、ならびに炎症における使用法

Country Status (7)

Country Link
US (2) US20060177447A1 (enExample)
EP (2) EP2192132A3 (enExample)
JP (1) JP2008532931A (enExample)
AU (1) AU2006212807A1 (enExample)
CA (1) CA2596390A1 (enExample)
IL (1) IL184567A0 (enExample)
WO (1) WO2006086396A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7801238B2 (en) * 2007-03-30 2010-09-21 Alcatel-Lucent Usa Inc. MIMO communication system with user scheduling based on reduced channel state information
US7611705B2 (en) * 2007-06-15 2009-11-03 National Cheng Kung University Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
TW201022288A (en) * 2008-06-30 2010-06-16 Novo Nordisk As Anti-human interleukin-20 antibodies
CN104829718A (zh) * 2008-07-08 2015-08-12 艾伯维公司 前列腺素e2结合蛋白及其用途
US8012478B2 (en) 2008-10-07 2011-09-06 National Cheng Kung University Use of anti-IL-20 antibody for treating stroke
US7837994B2 (en) * 2008-10-07 2010-11-23 National Cheng Kung University Use of anti-IL-20 antibody for treating osteoporosis
US8454956B2 (en) 2009-08-31 2013-06-04 National Cheng Kung University Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
CN107693791B (zh) 2010-02-26 2022-06-07 诺沃—诺迪斯克有限公司 包含稳定抗体的组合物
US20130136733A1 (en) 2010-05-28 2013-05-30 Novo Nordisk A/S Stable Multi-Dose Compositions Comprising an Antibody and a Preservative
US9221904B2 (en) 2012-07-19 2015-12-29 National Cheng Kung University Treatment of osteoarthritis using IL-20 antagonists
US8603470B1 (en) 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
US8852588B2 (en) 2012-08-07 2014-10-07 National Cheng Kung University Treating allergic airway disorders using anti-IL-20 receptor antibodies
GB201508841D0 (en) * 2015-05-22 2015-07-01 Isis Innovation Treatment
CN120383669B (zh) * 2025-04-24 2025-10-28 广东医科大学 一种重组人长效白细胞介素-22结合蛋白的制备方法及应用

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US578192A (en) * 1897-03-02 Henry h
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
DK368882A (da) 1981-08-25 1983-02-26 Alan John Kingsman Expessions vektorer
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4603044A (en) 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
EP0154316B1 (en) 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemically modified lymphokine and production thereof
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
CA1280080C (en) 1984-12-06 1991-02-12 Jacques Oberto Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides
DE3546806C2 (enExample) 1985-03-30 1991-03-28 Marc Genf/Geneve Ch Ballivet
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US6018026A (en) 1988-01-22 2000-01-25 Zymogenetics, Inc. Biologically active dimerized and multimerized polypeptide fusions
US5750375A (en) 1988-01-22 1998-05-12 Zymogenetics, Inc. Methods of producing secreted receptor analogs and biologically active dimerized polypeptide fusions
ES2092468T3 (es) 1988-01-22 1996-12-01 Zymogenetics Inc Metodos para producir analogos de receptores secretados.
US5567584A (en) * 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
ATE149841T1 (de) 1990-01-26 1997-03-15 Immunomedics Inc Impfstoffe gegen krebs und infektionskrankheiten
US5747334A (en) 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
US5208146A (en) 1990-11-05 1993-05-04 The Regents Of The University Of California Murine monoclonal anti-idiotype antibodies
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
JP3202999B2 (ja) 1991-01-31 2001-08-27 協和醗酵工業株式会社 肝移行性リポソーム製剤
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5436155A (en) * 1991-12-31 1995-07-25 Arch Development Corporation Isolated DNA encoding a somatostatin receptor
US5783384A (en) 1992-01-13 1998-07-21 President And Fellows Of Harvard College Selection of binding-molecules
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
CA2182498A1 (en) 1994-02-01 1995-08-10 William J. Larochelle Fusion proteins that include antibody and nonantibody portions
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5738846A (en) 1994-11-10 1998-04-14 Enzon, Inc. Interferon polymer conjugates and process for preparing the same
US5641655A (en) 1994-11-30 1997-06-24 Zymogenetics, Inc. Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
CA2237120C (en) 1995-11-09 2005-03-01 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in pichia methanolica
US5716808A (en) 1995-11-09 1998-02-10 Zymogenetics, Inc. Genetic engineering of pichia methanolica
US5723125A (en) 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
JP2002514049A (ja) 1996-07-17 2002-05-14 ザイモジェネティクス,インコーポレイティド ピヒア・メタノリカの栄養要求性突然変異体の製造
AU718510B2 (en) 1996-07-17 2000-04-13 Zymogenetics Inc. Transformation of pichia methanolica
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US5985614A (en) * 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
US5945511A (en) * 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US6486301B1 (en) * 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
CA2298439A1 (en) * 1997-08-06 1999-02-18 Zymogenetics, Inc. Lipocalin homologs
US6576743B1 (en) * 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
WO1999027103A1 (en) 1997-11-26 1999-06-03 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
US6274710B1 (en) * 1998-10-26 2001-08-14 Ludwig Institute For Cancer Research Antibodies which specifically bind T Cell inducible factors (TIFs)
BR9914777A (pt) 1998-10-26 2001-07-03 Ludwig Inst Cancer Res Moléculas isoladas de ácido nucléico que codificam os fatores induzìveis por células t (tifs), as proteìnas codificadas e os usos das mesmas
ATE458814T1 (de) * 1999-12-03 2010-03-15 Zymogenetics Inc Menschliches zytokinrezeptor
US6610286B2 (en) * 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
EP1246846B1 (en) 1999-12-23 2008-09-10 ZymoGenetics, Inc. Soluble interleukin-20 receptor
EP1337636B1 (en) * 2000-08-08 2006-10-18 ZymoGenetics, Inc. Soluble zcytor 11 cytokine receptors
DE60141546D1 (de) * 2000-09-15 2010-04-22 Zymogenetics Inc Polypeptide enthaltend extrazellulären Domäne von IL-20RA und/oderr IL-20RB
US20030022827A1 (en) * 2000-09-25 2003-01-30 Bertram Weiss Three new members of the cytokine receptor family class 2
NZ527396A (en) 2001-02-23 2007-12-21 Genetics Inst Llc Antibodies and fragments thereof for the binding of IL-22 and use therefore for treating inflammatory disorders
EP1370676A4 (en) * 2001-03-02 2004-09-22 Zymogenetics Inc CYTOKIN RECEPTOR FROM MOUSE
WO2002072607A2 (en) 2001-03-09 2002-09-19 Zymogenetics, Inc. Soluble heterodimeric cytokine receptor
BRPI0408683A (pt) * 2003-03-24 2006-03-28 Zymogenetics Inc métodos de produzir um anticorpo para um polipeptìdeo, anticorpo ou fragmento de anticorpo, método para reduzir ou inibir a proliferação ou diferenciação induzida por il-22 ou induzida por il-20 de células hematopoiéticas e progenitores de células hematopoiéticas, uso de um anticorpo, de uma composição de um anticorpo ou fragmento de anticorpo, uso de um antagonista de il-22 ou il-20, uso de um antagonista de il-22ra
EP1692180B1 (en) * 2003-11-21 2009-11-04 ZymoGenetics, Inc. Anti-il-20 antibodies and binding partners and methods of using in inflammation

Similar Documents

Publication Publication Date Title
JP2008532931A5 (enExample)
Shirai et al. Up-regulation of the expression of leucine-rich α2-glycoprotein in hepatocytes by the mediators of acute-phase response
Murray et al. Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFβ1, IL-13 and CCL2
JP2006502416A5 (enExample)
US8524866B2 (en) Antibodies to the alpha-7 nicotinic receptors and methods of treating inflammatory disorders with the same
JP2010536043A5 (enExample)
CN101680890B (zh) 用于评估人抑半胱氨酸蛋白酶蛋白c的比浊免疫测定
HRP20201323T1 (hr) Protutijela koja se specifično vežu na tl1a
JP2011526792A5 (enExample)
JP2002542157A5 (enExample)
JP2008530138A5 (enExample)
JP2014518883A5 (enExample)
JP2013518055A5 (enExample)
JP2016513644A5 (enExample)
JP2007536932A5 (enExample)
JP2012515551A5 (enExample)
RU2016149596A (ru) Новые полипептиды со специфическим связыванием и пути их применения
Zhang et al. New progress in diagnosis and treatment of pulmonary arterial hypertension
RU2011144166A (ru) Способы применения антител к il-22 человека
CN114478758B (zh) 靶向SARS-CoV-2的纳米抗体及制备方法和应用
JP2013534313A5 (enExample)
CN105968201A (zh) 针对前列腺特异性膜抗原的单域重链抗体
Stuiver et al. The autoantigen Ku is indistinguishable from NF IV, a protein forming multimeric protein-DNA complexes.
JP2015518829A5 (enExample)
KR20170127407A (ko) 특발성 폐섬유증의 치료 방법